Evidence map›Paper›PMID 33829009›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Chemotactic TEG3 Cells' Guiding Platforms Based on PLA Fibers Functionalized With the SDF-1α/CXCL12 Chemokine for Neural Regeneration Therapy.

Oscar Castaño, Ana López-Mengual, Diego Reginensi, Andreu Matamoros-Angles, Elisabeth Engel, José Antonio Del Rio

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Oscar CastañoElectronics and Biomedical Engineering, Universitat de Barcelona, Barcelona, Spain.
Ana López-MengualMolecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia, Parc Cientific de Barcelona, Barcelona, Spain.
Diego ReginensiSchool of Medicine, Universidad de Panamá, Panama City, Panama.
Andreu Matamoros-AnglesMolecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia, Parc Cientific de Barcelona, Barcelona, Spain.
Elisabeth EngelBiomaterials for Regenerative Therapies, Institute of Bioengineering of Catalonia, Parc Cientific de Barcelona, Barcelona, Spain.
José Antonio Del RioMolecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia, Parc Cientific de Barcelona, Barcelona, Spain.
Biomedical Research Networking Center on Neurodegenerative Diseases · ESBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESInstitute for Bioengineering of Catalonia · ESUniversidad de Panamá · PAUniversitat Politècnica de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(Following spinal cord injury, olfactory ensheathing cell (OEC) transplantation is a promising therapeutic approach in promoting functional improvement. Some studies report that the migratory properties of OECs are compromised by inhibitory molecules and potentiated by chemical concentration differences. Here we compare the attachment, morphology, and directionality of an OEC-derived cell line, TEG3 cells, seeded on functionalized nanoscale meshes of Poly(l/dl-lactic acid; PLA) nanofibers. The size of the nanofibers has a strong effect on TEG3 cell adhesion and migration, with the PLA nanofibers having a 950 nm diameter being the ones that show the best results. TEG3 cells are capable of adopting a bipolar morphology on 950 nm fiber surfaces, as well as a highly dynamic behavior in migratory terms. Finally, we observe that functionalized nanofibers, with a chemical concentration increment of SDF-1α/CXCL12, strongly enhance the migratory characteristics of TEG3 cells over inhibitory substrates.

Indexed as

cell migrationCXCL12electrospinninggradientsolfactory ensheathing cellsPLA nanofibersSDF-1alpha

Identifiers

PMID33829009
PMCPMC8019790
OpenAlexW3135912496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.